Two studies, one incorporating OSCC tissues and one concerning BC patient tissues, reported high PROX1 levels, along with other lymphatic-specific markers, such as LYVE-1 and podoplanin, in SLNs compared to control LNs, proving that active lymphangiogenesis does occur in the SLNs before metastasis. This evidence concerns the gene LYVE1 and breast cancer.